Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 269

1.

Erratum to: Prothrombin Complex Concentrate for Major Bleeding on Factor Xa Inhibitors: A Prospective Cohort Study.

Schulman S, Gross PL, Ritchie B, Nahirniak S, Lin Y, Lieberman L, Carrier M, Crowther MA, Ghosh I, Lazo-Langner A, Zondag M; Study Investigators.

Thromb Haemost. 2018 Nov 12. doi: 10.1055/s-0038-1675417. [Epub ahead of print]

PMID:
30419599
2.

Systematic reviews of guidelines and studies for single versus multiple unit transfusion strategies.

Shih AW, Liu A, Elsharawi R, Crowther MA, Cook RJ, Heddle NM.

Transfusion. 2018 Oct 21. doi: 10.1111/trf.14952. [Epub ahead of print]

PMID:
30345619
3.

Higher-risk APS: do we dare to DOAC?

Laureano M, Crowther MA.

Blood. 2018 Sep 27;132(13):1357-1358. doi: 10.1182/blood-2018-08-867036. No abstract available.

PMID:
30262580
4.

Weight-adjusted tinzaparin for the prevention of venous thromboembolism after bariatric surgery.

Tseng EK, Kolesar E, Handa P, Douketis JD, Anvari M, Tiboni M, Crowther MA, Siegal DM.

J Thromb Haemost. 2018 Oct;16(10):2008-2015. doi: 10.1111/jth.14263. Epub 2018 Aug 31.

PMID:
30099852
5.

Comparison of argatroban and fondaparinux for the management of patients with isolated heparin-induced thrombocytopenia.

Al-Eidan FAS, Alrawkan S, Alshammary H, Crowther MA.

Ann Hematol. 2018 Jul 12. doi: 10.1007/s00277-018-3422-6. [Epub ahead of print]

PMID:
30003318
6.

Soluble CD200 in secretory phase endometriosis endometrial venules may explain endometriosis pathophysiology and provide a novel treatment target.

Clark DA, Dmetrichuk JM, Dhesy-Thind S, Crowther MA, Arredondo JL.

J Reprod Immunol. 2018 Sep;129:59-67. doi: 10.1016/j.jri.2018.05.006. Epub 2018 May 21.

PMID:
29934094
7.

Low-molecular-weight heparin venous thromboprophylaxis in critically ill patients with renal dysfunction: A subgroup analysis of the PROTECT trial.

Pai M, Adhikari NKJ, Ostermann M, Heels-Ansdell D, Douketis JD, Skrobik Y, Qushmaq I, Meade M, Guyatt G, Geerts W, Walsh MW, Crowther MA, Friedrich JO, Burry L, Bellomo R, Brandão da Silva N, Costa Filho R, Cox MJ, Alves Silva S, Cook DJ; PROTECT (Prophylaxis for Thromboembolism in Critical Care Trial) Investigators.

PLoS One. 2018 Jun 1;13(6):e0198285. doi: 10.1371/journal.pone.0198285. eCollection 2018.

8.

Dual and triple antithrombotic therapies: current patterns of practice and controversies.

Crowther MA, Eikelboom JW.

Kardiol Pol. 2018;76(6):937-944. doi: 10.5603/KP.a2018.0112. Epub 2018 May 21.

9.
10.

Prothrombin Complex Concentrate for Major Bleeding on Factor Xa Inhibitors: A Prospective Cohort Study.

Schulman S, Gross PL, Ritchie B, Nahirniak S, Lin Y, Lieberman L, Carrier M, Crowther MA, Ghosh I, Lazo-Langner A, Zondag M; Study Investigators.

Thromb Haemost. 2018 May;118(5):842-851. doi: 10.1055/s-0038-1636541. Epub 2018 Mar 21.

PMID:
29564837
11.

Resolving Concerns With the Newer Oral Anticoagulant Medications: Is Hepatotoxicity a Real Concern?

Crowther MA, Lim W.

J Am Coll Cardiol. 2018 Mar 13;71(10):1114-1116. doi: 10.1016/j.jacc.2018.01.052. No abstract available.

PMID:
29519352
12.

Vitamin K Antagonists After 6 Months of Low-Molecular-Weight Heparin in Cancer Patients with Venous Thromboembolism.

Chai-Adisaksopha C, Iorio A, Crowther MA, de Miguel J, Salgado E, Zdraveska M, Fernández-Capitán C, Nieto JA, Barillari G, Bertoletti L, Monreal M; RIETE investigators.

Am J Med. 2018 Apr;131(4):430-437. doi: 10.1016/j.amjmed.2017.11.042. Epub 2017 Dec 20.

PMID:
29274307
13.

Assessment of the Measurement Error in Cyclosporine Levels Drawn Between Peripheral and Central Sources.

Shih AW, Crowther MA, Jamula E, El-Sharkawy R, Brown M, Paterson G, Lui M, Don-Wauchope AC.

Am J Clin Pathol. 2017 Dec 20;149(1):76-81. doi: 10.1093/ajcp/aqx145.

PMID:
29272889
14.

Red blood cell storage and in-hospital mortality: a secondary analysis of the INFORM randomised controlled trial.

Cook RJ, Heddle NM, Lee KA, Arnold DM, Crowther MA, Devereaux PJ, Ellis M, Figueroa P, Kurz A, Roxby D, Sessler DI, Sharon Y, Sobieraj-Teague M, Warkentin TE, Webert KE, Barty R, Liu Y, Eikelboom JW.

Lancet Haematol. 2017 Nov;4(11):e544-e552. doi: 10.1016/S2352-3026(17)30169-2. Epub 2017 Oct 8.

PMID:
29021123
15.

Association of body weight with efficacy and safety outcomes in phase III randomized controlled trials of direct oral anticoagulants: a systematic review and meta-analysis.

Boonyawat K, Caron F, Li A, Chai-Adisaksopha C, Lim W, Iorio A, Lopes RD, Garcia D, Crowther MA.

J Thromb Haemost. 2017 Jul;15(7):1322-1333. doi: 10.1111/jth.13701. Epub 2017 May 9. Review.

PMID:
28407368
16.

Reduced-Intensity Rivaroxaban for the Prevention of Recurrent Venous Thromboembolism.

Crowther MA, Cuker A.

N Engl J Med. 2017 Mar 30;376(13):1279-1280. doi: 10.1056/NEJMe1701628. Epub 2017 Mar 18. No abstract available.

PMID:
28316277
17.

Is low serum albumin level a significant predictor for the development of heparin-induced thrombocytopenia-thrombosis?

Al-Eidan FAS, Al-Gramish JA, Al-Zamil HA, Crowther MA.

Ann Hematol. 2017 Jun;96(6):1033-1036. doi: 10.1007/s00277-017-2971-4. Epub 2017 Mar 13.

PMID:
28289828
18.

Mortality outcomes in patients transfused with fresher versus older red blood cells: a meta-analysis.

Chai-Adisaksopha C, Alexander PE, Guyatt G, Crowther MA, Heddle NM, Devereaux PJ, Ellis M, Roxby D, Sessler DI, Eikelboom JW.

Vox Sang. 2017 Apr;112(3):268-278. doi: 10.1111/vox.12495. Epub 2017 Feb 20. Review.

PMID:
28220494
19.

Outcomes of low-molecular-weight heparin treatment for venous thromboembolism in patients with primary and metastatic brain tumours.

Chai-Adisaksopha C, Linkins LA, ALKindi SY, Cheah M, Crowther MA, Iorio A.

Thromb Haemost. 2017 Feb 28;117(3):589-594. doi: 10.1160/TH16-09-0680. Epub 2017 Jan 12.

PMID:
28078351
20.

Reversal of direct oral anticoagulants: a practical approach.

Shih AW, Crowther MA.

Hematology Am Soc Hematol Educ Program. 2016 Dec 2;2016(1):612-619. Review.

21.

Effect of Short-Term vs. Long-Term Blood Storage on Mortality after Transfusion.

Heddle NM, Cook RJ, Arnold DM, Liu Y, Barty R, Crowther MA, Devereaux PJ, Hirsh J, Warkentin TE, Webert KE, Roxby D, Sobieraj-Teague M, Kurz A, Sessler DI, Figueroa P, Ellis M, Eikelboom JW.

N Engl J Med. 2016 Nov 17;375(20):1937-1945. Epub 2016 Oct 24.

22.

Clinical evaluation of a hemochromatosis next-generation sequencing gene panel.

Lanktree MB, Sadikovic B, Waye JS, Levstik A, Lanktree BB, Yudin J, Crowther MA, Pare G, Adams PC.

Eur J Haematol. 2017 Mar;98(3):228-234. doi: 10.1111/ejh.12820. Epub 2016 Nov 11.

PMID:
27753142
23.

Direct oral anticoagulants (DOACs) and pregnancy: A plea for better information.

Ginsberg JS, Crowther MA.

Thromb Haemost. 2016 Sep 27;116(4):590-1. doi: 10.1160/TH16-08-0602. Epub 2016 Aug 25. No abstract available.

PMID:
27608925
24.

The effect of low-dose oral vitamin K supplementation on INR stability in patients receiving warfarin. A randomised trial.

Boonyawat K, Wang L, Lazo-Langner A, Kovacs MJ, Yeo E, Schnurr T, Schulman S, Crowther MA.

Thromb Haemost. 2016 Aug 30;116(3):480-5. doi: 10.1160/TH16-04-0320. Epub 2016 Jun 23.

PMID:
27346552
25.

Difficulties in establishing the diagnosis of immune thrombocytopenia: An agreement study.

Salib M, Clayden R, Clare R, Wang G, Warkentin TE, Crowther MA, Lim W, Nazi I, Kelton JG, Arnold DM.

Am J Hematol. 2016 Aug;91(8):E327-9. doi: 10.1002/ajh.24404. Epub 2016 Jun 1. No abstract available.

26.

Rivaroxaban for treatment of suspected or confirmed heparin-induced thrombocytopenia study.

Linkins LA, Warkentin TE, Pai M, Shivakumar S, Manji RA, Wells PS, Wu C, Nazi I, Crowther MA.

J Thromb Haemost. 2016 Jun;14(6):1206-10. doi: 10.1111/jth.13330. Epub 2016 May 10.

27.

Prevention of Recurrent Thrombosis in Antiphospholipid Syndrome: Different from the General Population?

Legault KJ, Ugarte A, Crowther MA, Ruiz-Irastorza G.

Curr Rheumatol Rep. 2016 May;18(5):26. doi: 10.1007/s11926-016-0573-0. Review.

PMID:
27032789
28.

Bridging anticoagulation for interruption of warfarin in a patient with atrial fibrillation.

Tseng E, Crowther MA, Hillis CM.

CMAJ. 2016 Mar 15;188(5):361-2. doi: 10.1503/cmaj.150867. Epub 2015 Dec 22. No abstract available.

29.

Rituximab plus standard of care for treatment of primary immune thrombocytopenia: a systematic review and meta-analysis.

Chugh S, Darvish-Kazem S, Lim W, Crowther MA, Ghanima W, Wang G, Heddle NM, Kelton JG, Arnold DM.

Lancet Haematol. 2015 Feb;2(2):e75-81. doi: 10.1016/S2352-3026(15)00003-4. Epub 2015 Feb 5. Review.

PMID:
26687612
30.

Rationale and Design of the Informing Fresh versus Old Red Cell Management (INFORM) Trial: An International Pragmatic Randomized Trial.

Eikelboom JW, Cook RJ, Barty R, Liu Y, Arnold DM, Crowther MA, Devereaux PJ, Ellis M, Figueroa P, Gallus A, Hirsh J, Kurz A, Roxby D, Sessler DI, Sharon Y, Sobieraj-Teague M, Warkentin TE, Webert KE, Heddle NM.

Transfus Med Rev. 2016 Jan;30(1):25-9. doi: 10.1016/j.tmrv.2015.11.002. Epub 2015 Nov 11.

PMID:
26651419
31.

Andexanet Alfa for the Reversal of Factor Xa Inhibitor Activity.

Siegal DM, Curnutte JT, Connolly SJ, Lu G, Conley PB, Wiens BL, Mathur VS, Castillo J, Bronson MD, Leeds JM, Mar FA, Gold A, Crowther MA.

N Engl J Med. 2015 Dec 17;373(25):2413-24. doi: 10.1056/NEJMoa1510991. Epub 2015 Nov 11.

32.

Risk of thromboembolism, recurrent hemorrhage, and death after warfarin therapy interruption for intracranial hemorrhage.

Witt DM, Clark NP, Martinez K, Schroeder A, Garcia D, Crowther MA, Ageno W, Dentali F, Ye X, Hylek E, Delate T.

Thromb Res. 2015 Nov;136(5):1040-4. doi: 10.1016/j.thromres.2015.10.002. Epub 2015 Oct 9.

PMID:
26454758
33.

Coronary artery calcification, cardiovascular events, and death: a prospective cohort study of incident patients on hemodialysis.

Wilkieson TJ, Rahman MO, Gangji AS, Voss M, Ingram AJ, Ranganath N, Goldsmith CH, Kotsamanes CZ, Crowther MA, Rabbat CG, Clase CM.

Can J Kidney Health Dis. 2015 Aug 12;2:29. doi: 10.1186/s40697-015-0065-6. eCollection 2015.

34.

Antidotes for novel oral anticoagulants: current status and future potential.

Crowther M, Crowther MA.

Arterioscler Thromb Vasc Biol. 2015 Aug;35(8):1736-45. doi: 10.1161/ATVBAHA.114.303402. Epub 2015 Jun 18. Review.

PMID:
26088576
35.

Warfarin-induced venous limb ischemia/gangrene complicating cancer: a novel and clinically distinct syndrome.

Warkentin TE, Cook RJ, Sarode R, Sloane DA, Crowther MA.

Blood. 2015 Jul 23;126(4):486-93. doi: 10.1182/blood-2015-01-622787. Epub 2015 May 15.

36.

Acute phase treatment of VTE: Anticoagulation, including non-vitamin K antagonist oral anticoagulants.

Hillis C, Crowther MA.

Thromb Haemost. 2015 Jun;113(6):1193-202. doi: 10.1160/TH14-12-1036. Epub 2015 May 7. Review. Erratum in: Thromb Haemost. 2015 Jul;114(1):210.

PMID:
25948149
37.

A double-blind, randomized controlled trial of the prevention of clinically important venous thromboembolism after isolated lower leg fractures.

Selby R, Geerts WH, Kreder HJ, Crowther MA, Kaus L, Sealey F; D-KAF (Dalteparin in Knee-to-Ankle Fracture) Investigators.

J Orthop Trauma. 2015 May;29(5):224-30. doi: 10.1097/BOT.0000000000000250.

PMID:
25900749
38.

Aspirin in secondary prevention of recurrent venous thromboembolism.

Boonyawat K, Crowther MA.

J Thromb Thrombolysis. 2015 Apr;39(3):392-4. doi: 10.1007/s11239-015-1196-4. Review. No abstract available.

PMID:
25740464
39.

Examining the clinical use of hemochromatosis genetic testing.

Lanktree MB, Lanktree BB, Paré G, Waye JS, Sadikovic B, Crowther MA.

Can J Gastroenterol Hepatol. 2015 Jan-Feb;29(1):41-5.

40.

The Canadian Choosing Wisely campaign: the Canadian Hematology Society's top five tests and treatments.

Hillis CM, Schimmer AD, Couban S, Crowther MA.

Ann Hematol. 2015 Apr;94(4):541-5. doi: 10.1007/s00277-015-2304-4. Epub 2015 Feb 1. Review.

PMID:
25637447
41.

Venous thromboembolism prophylaxis in critically ill patients.

Boonyawat K, Crowther MA.

Semin Thromb Hemost. 2015 Feb;41(1):68-74. doi: 10.1055/s-0034-1398386. Epub 2015 Jan 16. Review.

PMID:
25594495
42.

Evaluation of the appropriateness of frozen plasma usage after introduction of prothrombin complex concentrates: a retrospective study.

Shih AW, Kolesar E, Ning S, Manning N, Arnold DM, Crowther MA.

Vox Sang. 2015 Apr;108(3):274-80. doi: 10.1111/vox.12226. Epub 2014 Dec 30.

PMID:
25556889
43.

Failure of anticoagulant thromboprophylaxis: risk factors in medical-surgical critically ill patients*.

Lim W, Meade M, Lauzier F, Zarychanski R, Mehta S, Lamontagne F, Dodek P, McIntyre L, Hall R, Heels-Ansdell D, Fowler R, Pai M, Guyatt G, Crowther MA, Warkentin TE, Devereaux PJ, Walter SD, Muscedere J, Herridge M, Turgeon AF, Geerts W, Finfer S, Jacka M, Berwanger O, Ostermann M, Qushmaq I, Friedrich JO, Cook DJ; PROphylaxis for ThromboEmbolism in Critical Care Trial Investigators.

Crit Care Med. 2015 Feb;43(2):401-10. doi: 10.1097/CCM.0000000000000713.

PMID:
25474533
44.

Plasma exchange to remove HIT antibodies: dissociation between enzyme-immunoassay and platelet activation test reactivities.

Warkentin TE, Sheppard JA, Chu FV, Kapoor A, Crowther MA, Gangji A.

Blood. 2015 Jan 1;125(1):195-8. doi: 10.1182/blood-2014-07-590844. Epub 2014 Nov 18.

45.

A 42-year-old man with elevated ferritin.

Lanktree MB, Sadikovic B, Crowther MA.

CMAJ. 2015 Aug 11;187(11):820-1. doi: 10.1503/cmaj.140259. Epub 2014 Oct 6. Review. No abstract available.

46.

Laboratory measurement of the anticoagulant activity of the non-vitamin K oral anticoagulants.

Cuker A, Siegal DM, Crowther MA, Garcia DA.

J Am Coll Cardiol. 2014 Sep 16;64(11):1128-39. doi: 10.1016/j.jacc.2014.05.065. Review.

47.

Unusual venous thrombosis.

Douketis JD, Carrier M, Crowther MA.

CMAJ. 2014 Jun 10;186(9):697-8. doi: 10.1503/cmaj.114-0043. No abstract available.

48.

Symptomatic venous thromboembolism uncommon without thromboprophylaxis after isolated lower-limb fracture: the knee-to-ankle fracture (KAF) cohort study.

Selby R, Geerts WH, Kreder HJ, Crowther MA, Kaus L, Sealey F.

J Bone Joint Surg Am. 2014 May 21;96(10):e83. doi: 10.2106/JBJS.M.00236.

PMID:
24875035
49.

γT -S195A thrombin reduces the anticoagulant effects of dabigatran in vitro and in vivo.

Sheffield WP, Lambourne MD, Eltringham-Smith LJ, Bhakta V, Arnold DM, Crowther MA.

J Thromb Haemost. 2014 Jul;12(7):1110-5. doi: 10.1111/jth.12601. Epub 2014 Jun 19.

50.

Venous thromboembolism in older adults: A community-based study.

Spencer FA, Gurwitz JH, Schulman S, Linkins LA, Crowther MA, Ginsberg JS, Lee AY, Saczynski JS, Anand S, Lessard D, Emery C, Huang W, Goldberg RJ.

Am J Med. 2014 Jun;127(6):530-7.e3. doi: 10.1016/j.amjmed.2014.02.011. Epub 2014 Feb 18.

PMID:
24561112

Supplemental Content

Loading ...
Support Center